Literature DB >> 28238179

FIT and M2-PK: a marriage of convenience!

Cesare Hassan1, Alessandro Repici2,3, Sameer Alawadhi4, Carlo Senore5.   

Abstract

Year:  2017        PMID： 28238179     DOI： 10.1007/s11739-017-1639-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  11 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT.

Authors:  Cristina Zaccaro; Ilaria Maria Saracino; Giulia Fiorini; Natale Figura; John Holton; Valentina Castelli; Valeria Pesci; Luigi Gatta; Dino Vaira
Journal:  Intern Emerg Med       Date:  2017-02-02       Impact factor: 3.397

3.  The impact of immunochemical faecal occult blood testing on colorectal cancer incidence.

Authors:  Leonardo Ventura; Paola Mantellini; Grazia Grazzini; Guido Castiglione; Carlotta Buzzoni; Tiziana Rubeca; Claudio Sacchettini; Eugenio Paci; Marco Zappa
Journal:  Dig Liver Dis       Date:  2013-09-04       Impact factor: 4.088

4.  Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).

Authors:  Manuel Zorzi; Carlo Senore; Filippo Da Re; Alessandra Barca; Luigina Ada Bonelli; Renato Cannizzaro; Giovanni de Pretis; Lucia Di Furia; Emilio Di Giulio; Paola Mantellini; Carlo Naldoni; Romano Sassatelli; Douglas K Rex; Marco Zappa; Cesare Hassan
Journal:  Gut       Date:  2016-02-19       Impact factor: 23.059

5.  Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.

Authors:  Maaike J Denters; Marije Deutekom; Patrick M Bossuyt; An K Stroobants; Paul Fockens; Evelien Dekker
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

6.  Serrated lesions of the colorectum: review and recommendations from an expert panel.

Authors:  Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

7.  Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test.

Authors:  C Hassan; P Giorgi Rossi; L Camilloni; D K Rex; B Jimenez-Cendales; E Ferroni; P Borgia; A Zullo; G Guasticchi
Journal:  Aliment Pharmacol Ther       Date:  2012-10-04       Impact factor: 8.171

8.  Screening for colorectal cancer in Italy: 2007 survey.

Authors:  Manuel Zorzi; Chiara Fedato; Carlo Naldoni; Romano Sassatelli; Priscilla Sassoli De' Bianchi; Carlo Senore; Carmen Beatriz Visioli; Carla Cogo
Journal:  Epidemiol Prev       Date:  2009 May-Jun       Impact factor: 1.901

9.  Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.

Authors:  Manuel Zorzi; Ugo Fedeli; Elena Schievano; Emanuela Bovo; Stefano Guzzinati; Susanna Baracco; Chiara Fedato; Mario Saugo; Angelo Paolo Dei Tos
Journal:  Gut       Date:  2014-09-01       Impact factor: 23.059

10.  Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).

Authors:  Manuel Zorzi; Carlo Senore; Filippo Da Re; Alessandra Barca; Luigina Ada Bonelli; Renato Cannizzaro; Renato Fasoli; Lucia Di Furia; Emilio Di Giulio; Paola Mantellini; Carlo Naldoni; Romano Sassatelli; Douglas Rex; Cesare Hassan; Marco Zappa
Journal:  Gut       Date:  2014-09-16       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.